We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-3.05%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$52.7B
AUM Growth
-$2.48B
(-4.5%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
0.49%
Top 10 Holdings %
Top 10 Hldgs %
16.27%
Holding
2,367
New
187
Increased
1,008
Reduced
966
Closed
158
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$237M |
| 2 |
Pfizer
PFE
|
+$200M |
| 3 |
Moderna
MRNA
|
+$143M |
| 4 |
EPAM Systems
EPAM
|
+$106M |
| 5 |
Gilead Sciences
GILD
|
+$94.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Target
TGT
|
+$138M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$135M |
| 3 |
AngloGold Ashanti
AU
|
+$112M |
| 4 |
Costco
COST
|
+$111M |
| 5 |
Microsoft
MSFT
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.94% |
| 2 | Healthcare | 15.7% |
| 3 | Industrials | 11.74% |
| 4 | Financials | 11.69% |
| 5 | Consumer Discretionary | 10.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Clorox
CLX
$13B
| $45.7M | 0.09% |
328,483
-162,136
| -33% | -$24.8M |
|
277
Dow Inc
DOW
$22.1B
| $45.6M | 0.09% |
715,888
+204,596
| +40% | +$12.3M |
|
278
Emcor
EME
$35.7B
| $45.5M | 0.09% |
403,784
+99,035
| +32% | +$11.7M |
|
279
Cencora
COR
$62B
| $45.1M | 0.09% |
291,514
-340,924
| -54% | -$48.2M |
|
280
Cracker Barrel
CBRL
$1.25B
| $44.7M | 0.08% |
378,238
+120,454
| +47% | +$14.9M |
|
281
lululemon athletica
LULU
$14.5B
| $44.4M | 0.08% |
121,575
-9,601
| -7% | -$3.12M |
|
282
Equinix
EQIX
$103B
| $44.2M | 0.08% |
59,561
+18,319
| +44% | +$13.2M |
|
283
Mohawk Industries
MHK
$9.19B
| $43.9M | 0.08% |
353,652
+15,552
| +5% | +$2.33M |
|
284
Concentrix
CNXC
$1.56B
| $43.7M | 0.08% |
262,539
+100,542
| +62% | +$19.1M |
|
285
Salesforce
CRM
$162B
| $43.5M | 0.08% |
204,794
+48,944
| +31% | +$10.5M |
|
286
West Pharmaceutical
WST
$24.8B
| $43.2M | 0.08% |
105,145
-17,388
| -14% | -$6.81M |
|
287
Alaska Air
ALK
$5.27B
| $43M | 0.08% |
741,657
+208,179
| +39% | +$11.4M |
|
288
Virtu Financial
VIRT
$4.92B
| $43M | 0.08% |
1,155,682
-749,786
| -39% | -$24.8M |
|
289
NXP Semiconductors
NXPI
$58.9B
| $42.9M | 0.08% |
232,010
+75,234
| +48% | +$14.8M |
|
290
Yelp
YELP
$1.33B
| $42.5M | 0.08% |
1,246,829
+333,538
| +37% | +$11.5M |
|
291
Viatris
VTRS
$18.7B
| $42.4M | 0.08% |
3,898,552
+3,232,441
| +485% | +$42.6M |
|
292
Albertsons Companies
ACI
$5.89B
| $42.1M | 0.08% |
1,267,312
+381,295
| +43% | +$11.9M |
|
293
Pentair
PNR
$10.7B
| $42M | 0.08% |
775,190
+128,531
| +20% | +$7.78M |
|
294
Rollins
ROL
$17.9B
| $41.8M | 0.08% |
1,192,244
-551,306
| -32% | -$17.9M |
|
295
Ametek
AME
$58B
| $41.7M | 0.08% |
313,324
-18,352
| -6% | -$2.47M |
|
296
Revvity
RVTY
$12.9B
| $41.4M | 0.08% |
237,542
-138,313
| -37% | -$24.6M |
|
297
Fidelity National Financial
FNF
$12.9B
| $41.4M | 0.08% |
881,395
-183,582
| -17% | -$8.78M |
|
298
ResMed
RMD
$31.9B
| $41.3M | 0.08% |
170,395
-85,459
| -33% | -$20.7M |
|
299
CACI
CACI
$14.3B
| $41.2M | 0.08% |
136,625
-62,595
| -31% | -$17.3M |
|
300
Fastenal
FAST
$59.8B
| $41.1M | 0.08% |
1,383,154
-366,370
| -21% | -$10.2M |
|
Similar funds
VGA
AQR Capital Management's Q1 2022 Portfolio in Review
As of Q1 2022, AQR Capital Management held 2,367 positions worth $52.7B, down 4.5% from $55.2B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
AQR Capital Management's Q1 2022 filing shows 187 new, 1,008 increased, 966 reduced and 158 closed positions. Its largest new stake was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M. The largest sale was Target, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.
- AQR Capital Management's largest Q1 2022 buy was Carnival Corporation Ltd: 1,737,168 shares worth $34.8M.
- AQR Capital Management added most to Meta Platforms (Facebook) in Q1 2022, an estimated $237M increase.
- AQR Capital Management's biggest Q1 2022 reduction was Target, cutting an estimated $138M.
- AQR Capital Management fully exited Xilinx Inc in Q1 2022, selling an estimated $25.4M.
- AQR Capital Management's ten largest holdings make up 16% of its $52.7B portfolio in Q1 2022.
- AQR Capital Management opened 187 new positions and closed 158 in Q1 2022.
- AQR Capital Management's portfolio value fell 4.5% quarter-over-quarter to $52.7B.
Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.